期刊文献+

罗格列酮对变应性鼻炎小鼠galectin-9、tim-3信号和炎性分子表达的影响 被引量:2

Effect of rosiglitazone on the expression of galectin-9 and tim-3 and inflammatory factors in allergic rhinitis mice
原文传递
导出
摘要 目的研究PPAR-γ激动剂罗格列酮(ROS)对变应性鼻炎小鼠鼻黏膜半乳糖凝集素-9(galectin-9)和T细胞免疫球蛋白黏蛋白分子-3(tim-3)表达的影响。方法应用卵清蛋白(OVA)致敏建立小鼠变应性鼻炎模型,应用免疫组化及Real Time-PCR方法检测ROS对小鼠鼻黏膜中galectin-9和tim-3表达影响,应用ELISA法检测小鼠血清中IL-4、IL-5、IFN-γ含量。结果变应性鼻炎(AR)小鼠鼻黏膜中galectin-9和tim-3表达较正常对照组明显增高,罗格列酮及地塞米松治疗后galectin-9和tim-3的表达降低。与正常对照组比较,变应性鼻炎小鼠血清IL-4、IL-5含量明显升高,而IFN-γ含量明显减低;罗格列酮组和地塞米松组IL-4和IL-5含量较AR组降低,IFN-γ含量上调。结论罗格列酮抑制变应性鼻炎黏膜炎症反应,可能与降低鼻黏膜galectin-9和tim-3的表达相关。 Objective To research the effect of PPAR- T ligand agonist rosiglitazone on galectin-9 and tim-3 expression in nasal mucosa and contents of ~qammatory factors in serum of allergic rhinitis(AR) mice. Methods Fourty mice were divided averagely into 4 groups: AR group, Rosiglitazone(ROS) group, Dexamethasone(DEX) group and normal group. The mice were immunized by ovalbumin(OVA) at days 1 and 14,, the sensitized mice were exposed to OVA each day from day 21 to 27. The mice of ROS group and DEX group received the test drugs from day 21 to day 27 after the challenge, mice in normal group were exposed to the saline. Immunohistochemical staining was used to examine the galectin-9 and tim-3 expression in nasal mucosa. Real time-PCR was performed to investigate the level of mRNA expression of complement galectin-9 and tim-3 in nasal mucosa. ELISA was performed to investigate the level of proteinum expression of IL-4, IL-5 and IFN- y, in serum. Results Expression levels of galectin-9 and tim-3 were higher in AR group than in N group, Dex and ROS can downregulate their expression. The levels of IL-4 and IL-5 in serum were decreased, but increased for IFN- y in serum in AR group than in N group; however, increased for IL-4 and IL-5, decreased for IFN- y in Dex and ROS groups than in AR group. Conclusion The treated effect of rosiglitazone on allergic rhinitis may be related to inhibition of galectin-9 and tim-3 expression.
出处 《解剖科学进展》 CAS 2013年第2期129-132,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金资助项目(No.81100708) 辽宁省自然科学基金资助项目(No.20092120)
  • 相关文献

参考文献11

  • 1DaynesRA, Jones DC. Emerging roles of PPARs in inflammation and immunity[J]. Nat Rev Immunol, 2002, 2: 7480-7591.
  • 2韩佳利,任重,姜学钧.变应性鼻炎小鼠鼻黏膜中半乳糖凝集素3和9的表达[J].中华耳鼻咽喉头颈外科杂志,2008,43(7):504-508. 被引量:3
  • 3韩佳利,任重,姜学钧.Tim-3在变应性鼻炎小鼠鼻黏膜中的表达及其作用的实验研究[J].中国医科大学学报,2008,37(4):439-441. 被引量:8
  • 4Belvisi MG, Mitchell JA. Targeting PPAR receptors in the airway for the treatment of in-ammatory lung disease[J]. Br J Pharmacol, 2009, 158:994-1003.
  • 5Lee KS, Park SJ, Kmi SR, et al. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptorgammain amurinemodelof toluenediisocyanate induced asthma[J]. J Immunol, 2006, 15(177): 5248-5257.
  • 6Bousquet J, Van Cauwenherge P, Khaltaev N, et al. Allergic rhittitis and its impact on asThma[J]. J Allergy Clin Immunol, 2001, 10: 147-334.
  • 7罗建海,廖福干,廖志鹏.IL-6基因多态性与变应性鼻炎的关联性[J].解剖科学进展,2010,16(5):442-444. 被引量:5
  • 8Yamamoto H, Kashio Y, Shoji H, et al. Involvement of galectin-9 in guinea pig allergic airway inflammation[J]. Int Arch Allergy Immunol, 2007, 143 (Suppl 1): 95-105.
  • 9Zhu C, Anderson AC, Sehubart A, et al. The Tim-3 ligand galeetin-9 negatively regulates T helper type 1 immunity[J]. Nat Immunol, 2005, 6: 1245-1252.
  • 10Sziksz E, Kozma GT, P611inger E, et al. Galectin-9 in Allergic Airway Inflammation and Hyper-Responsiveness in Mice[J]. Int Arch Allergy Immunol, 2010,151:308 -317.

二级参考文献22

  • 1陈靖,李添应,冯练强,林志斌.变应性鼻炎患者外周血单个核细胞变应原刺激与白细胞介素4和13表达的关系[J].中华耳鼻咽喉科杂志,2004,39(12):758-759. 被引量:8
  • 2唐任光,韦叶生,陈宏明,方文珠,龙显科,袁锡华.白细胞介素6基因型及血清水平与食管癌的相关性研究[J].中华医学杂志,2007,87(16):1126-1128. 被引量:10
  • 3Leffler H, Carlsson S, Hedlund M, et al. Introduction to galectins. Glycoconj J, 2004,19(7-9) : 433-440.
  • 4Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol, 2005, 136: 385-400.
  • 5Zuberi RI, Hsu DK, Kalayci O, et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol, 2004, 165 : 2045-2053.
  • 6Bousquet J, Van Cauwenberge P, Khahaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol, 2001, 108(5 Suppl) : 147-334.
  • 7Romagnani S. Immunologic influences on allergy and the TH1/ TH2 balance. J Allergy Clin Immunol, 2004, 113:395-400.
  • 8Chen HY, Sharma BB, Yu L,et al. Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J Immunol, 2006, 177: 4991-4997.
  • 9Kimata H Enhancement of IgE production in B cells by neutrophils via galeetin-3 in IgE-associated atopic eczema/dermatitis syndrome. Int Arch Allergy Immunol, 2002, 128:168-170.
  • 10Hirashima M. Ecalectin as T cell-derived eosinophil chemoattractant. Int Arch Allergy Immunol, 1999, 120 Suppl 1: 7-10.

共引文献13

同被引文献30

  • 1罗建海,廖福干,廖志鹏.IL-6基因多态性与变应性鼻炎的关联性[J].解剖科学进展,2010,16(5):442-444. 被引量:5
  • 2林健,曹平.过敏性鼻炎豚鼠模型复制的初步报告[J].中国实验动物学杂志,1994,4(3):176-178. 被引量:1
  • 3Skoner DP, LaForce CF, Nathan RA, et al. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis[J]. Allergy Asthma Proc, 2014, 35(4): 338-345.
  • 4Blaiss MS, Fromer LM, Jacob-Nara JA, et al. Current Allergic Rhinitis Experiences Survey(CARES): Health-care practitioners' awareness, attitudes and practices[J]. Allergy Asthma Proc, 2014, 35(4): 316-322.
  • 5Canuel M, Lebel G. Epidemiology of allergic rhinitis in Quebec: from a 2008 population-based survey[J]. Chronic Dis Inj Can, 2014, 34(3): 163-168.
  • 6Josefowicz SZ, Niec RE, Kim HY, et al. Extrathymieally generated regulatory T ceils control mueosal TH2 inflammation[J]. Nature, 2012, 482(7385): 395-399.
  • 7Dellapenna D. A decade of progress in understanding vitamin E synthesis in plants[J]. J Plant Physiol, 2005, 162(7): 729-737.
  • 8Jiang S, Pan Z, Li H, et al. Meta-analysis: low-dose intake of vitamin e combined with other vitamins or minerals may decrease all-cause mortality[J]. J Nutr Sci Vitaminol, 2014, 60(3): 194-205.
  • 9Mo JH, Kang EK, Quan SH, et al. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model[J]. Allergy, 201 i, 66(2): 279-286.
  • 10Iwasaki M, Saito K, Takemura M, et aL TNF- ct contributes to the development of allergic rhinitis in mice[J]. J Allergy Clin Immuno, 2003, 112(1): 134-140.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部